M Silvasti

1.1k total citations
57 papers, 921 citations indexed

About

M Silvasti is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Nutrition and Dietetics. According to data from OpenAlex, M Silvasti has authored 57 papers receiving a total of 921 indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Pulmonary and Respiratory Medicine, 41 papers in Physiology and 5 papers in Nutrition and Dietetics. Recurrent topics in M Silvasti's work include Asthma and respiratory diseases (41 papers), Inhalation and Respiratory Drug Delivery (33 papers) and Respiratory and Cough-Related Research (26 papers). M Silvasti is often cited by papers focused on Asthma and respiratory diseases (41 papers), Inhalation and Respiratory Drug Delivery (33 papers) and Respiratory and Cough-Related Research (26 papers). M Silvasti collaborates with scholars based in Finland, United Kingdom and Germany. M Silvasti's co-authors include Kari Laurikainen, P Karttunen, H Tukiainen, M Vidgren, Matti Uusitupa, Gary R. Pitcairn, Stephen P. Newman, Ilkka Penttilä, K. Malmström and Peter H. Hirst and has published in prestigious journals such as American Journal of Clinical Nutrition, Pharmaceutical Research and Clinical Pharmacology & Therapeutics.

In The Last Decade

M Silvasti

57 papers receiving 867 citations

Peers

M Silvasti

PRM

PHYSI

PPCH

AH Morice United Kingdom

Carl Burgess New Zealand

P Karttunen Finland

Michael Karamouzis Greece

Ashish Sharma India

Mark Knox Ireland

Benedito Jorge Pereira Brazil

Jana Kopincová Slovakia

E.A. Laude United Kingdom

Komei Saito Japan

AH Morice United Kingdom

M Silvasti

925 ×1.5

PRM

684 ×1.3

PHYSI

36 ×0.3

53 ×0.6

35 ×0.6

PPCH

Citations per year, relative to M Silvasti M Silvasti (= 1×) peers AH Morice

Countries citing papers authored by M Silvasti

Since Specialization

Citations

This map shows the geographic impact of M Silvasti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Silvasti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Silvasti more than expected).

Fields of papers citing papers by M Silvasti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Silvasti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Silvasti. The network helps show where M Silvasti may publish in the future.

Co-authorship network of co-authors of M Silvasti

This figure shows the co-authorship network connecting the top 25 collaborators of M Silvasti. A scholar is included among the top collaborators of M Silvasti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Silvasti. M Silvasti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Randell, Jukka, et al.. (2005). Safety of formoterol after cumulative dosing via Easyhaler® and Aerolizer®. Respiratory Medicine. 99(12). 1485–1493. 11 indexed citations

Dubakienė, Rūta, et al.. (2005). Clinically Equivalent Bronchodilatation Achieved with Formoterol Delivered via Easyhaler® and Aerolizer®. Respiration. 73(4). 441–448. 5 indexed citations

Kirjavainen, Merja, et al.. (2004). Equivalent lung deposition of budesonide in vivo: a comparison of dry powder inhalers using a pharmacokinetic method. British Journal of Clinical Pharmacology. 59(2). 167–173. 31 indexed citations

Tukiainen, H, et al.. (2002). Safety, tolerability and acceptability of two dry powder inhalers in the administration of budesonide in steroid-treated asthmatic patients. Respiratory Medicine. 96(4). 221–229. 17 indexed citations

Hirst, Peter H., et al.. (2001). A comparison of the lung deposition of budesonide from Easyhaler®, Turbuhaler®and pMDI plus spacer in asthmatic patients. Respiratory Medicine. 95(9). 720–727. 61 indexed citations

Laurikainen, Kari, et al.. (2000). BECLOMETHASONE DIPROPIONATE EASYHALER® IS AS EFFECTIVE AS BUDESONIDE TURBOHALER® IN THE CONTROL OF ASTHMA AND IS PREFERRED BY PATIENTS. International Journal of Clinical Practice. 54(6). 368–372. 15 indexed citations

Koskela, Tuomas, J. Hedman, Heikki Ekroos, et al.. (2000). Equivalence of Two Steroid-Containing Inhalers: Easyhaler Multidose Powder Inhaler Compared with Conventional Aerosol with Large-Volume Spacer. Respiration. 67(2). 194–202. 19 indexed citations

Koskela, Tuomas, et al.. (2000). Efficacy of salbutamol via Easyhaler®unaffected by low inspiratory flow. Respiratory Medicine. 94(12). 1229–1233. 23 indexed citations

Malmström, K., Ritva Sorva, & M Silvasti. (1999). Application and efficacy of the multi‐dose powder inhaler, Easyhaler^Â®, in children with asthma. Pediatric Allergy and Immunology. 10(1). 66–70. 26 indexed citations

10.

Nieminen, Markku M., J. Kokkarinen, Kari Liippo, et al.. (1998). A New Beclomethasone Dipropionate Multidose Powder Inhaler in the Treatment of Bronchial Asthma. Respiration. 65(4). 275–281. 12 indexed citations

11.

Alanko, Kristiina, Aija Knuuttila, Jukka Laitinen, et al.. (1998). Comparison of a Multidose Powder Inhaler Containing Beclomethasone Dipropionate (BDP) with a BDP Metered Dose Inhaler with Spacer in the Treatment of Asthmatic Patients. Clinical Drug Investigation. 16(2). 101–110. 8 indexed citations

12.

Nieminen, Markku M., M Vidgren, Kari Laurikainen, et al.. (1994). Easyhaler® a Novel Multiple Dose Powder Inhaler: Clinically Equivalent to Salbutamol Metered Dose Inhaler and Easier to Use. Respiration. 61(1). 37–41. 25 indexed citations

13.

Saano, Veijo, et al.. (1991). The Effect of ATP on the Ciliary Activity of Normal and Pathological Human Respiratory Mucosa in Vitro. Acta Oto-Laryngologica. 111(1). 130–134. 12 indexed citations

14.

Saano, Veijo, et al.. (1990). Effects of Intravenous ATP on Tracheal Ciliary Activity, Airway Resistance and Haemodynamics in Rats. Pharmacology & Toxicology. 66(4). 303–306. 5 indexed citations

15.

Karttunen, P, M Silvasti, Pasi Virta, Veijo Saano, & Juhani Nuutinen. (1990). The Effects of Vadocaine, Dextromethorphan, Diphenhydramine and Hydroxyzine on the Ciliary Beat Frequency in Rats in Vitro. Pharmacology & Toxicology. 67(2). 159–161. 9 indexed citations

16.

Vilkka, V, Pirkko Brander, A. Hakulinen, et al.. (1990). Once-daily theophylline in the treatment of nocturnal asthma. European Journal of Clinical Pharmacology. 39(3). 241–243. 4 indexed citations

17.

Nuutinen, J., Elina Holopainen, Henrik Malmberg, et al.. (1989). Terfenadine with or without phenylpropanolamine in the treatment of seasonal allergic rhinitis. Clinical & Experimental Allergy. 19(6). 603–608. 5 indexed citations

18.

Uusitupa, Matti, Onni Siitonen, Kaisa Savolainen, et al.. (1989). Metabolic and nutritional effects of long-term use of guar gum in the treatment of noninsulin-dependent diabetes of poor metabolic control. American Journal of Clinical Nutrition. 49(2). 345–351. 68 indexed citations

19.

Nuutinen, J., P Karttunen, & M Silvasti. (1988). Activation of mucociliary function in chronic rhinitis: a placebo-controlled study. European Archives of Oto-Rhino-Laryngology. 245(5). 284–286. 7 indexed citations

20.

Tuomilehto, Jaakko, M Silvasti, Antti Aro, et al.. (1988). Long term treatment of severe hypercholesterolaemia with guar gum. Atherosclerosis. 72(2-3). 157–162. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact